PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 187 filers reported holding PDL BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $29,000 | -80.0% | 10,312 | -80.5% | 0.00% | -100.0% |
| Q4 2017 | $145,000 | -19.4% | 52,800 | -0.4% | 0.00% | 0.0% |
| Q3 2017 | $180,000 | -93.2% | 53,000 | -93.7% | 0.00% | -94.4% |
| Q2 2016 | $2,628,000 | -37.6% | 836,862 | -33.8% | 0.05% | -39.3% |
| Q1 2016 | $4,211,000 | +6002.9% | 1,264,679 | +11610.0% | 0.09% | +8800.0% |
| Q2 2015 | $69,000 | -9.2% | 10,800 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $76,000 | -87.4% | 10,800 | -85.8% | 0.00% | -90.0% |
| Q3 2013 | $605,000 | – | 75,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |